| Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms P Scudieri, E Caci, A Venturini, E Sondo, G Pianigiani, C Marchetti, ... The Journal of physiology 593 (17), 3829-3848, 2015 | 103 | 2015 |
| Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA I Donadon, E Bussani, F Riccardi, D Licastro, G Romano, G Pianigiani, ... Nucleic acids research 47 (14), 7618-7632, 2019 | 43 | 2019 |
| Current status and future perspectives in targeted therapy of NPM1-mutated AML R Ranieri, G Pianigiani, S Sciabolacci, VM Perriello, A Marra, V Cardinali, ... Leukemia 36 (10), 2351-2367, 2022 | 41 | 2022 |
| Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model I Donadon, M Pinotti, K Rajkowska, G Pianigiani, E Barbon, E Morini, ... Human molecular genetics 27 (14), 2466-2476, 2018 | 39 | 2018 |
| Cross talk between spliceosome and microprocessor defines the fate of pre‐mRNA C Mattioli, G Pianigiani, F Pagani Wiley Interdisciplinary Reviews: RNA 5 (5), 647-658, 2014 | 28 | 2014 |
| A competitive regulatory mechanism discriminates between juxtaposed splice sites and pri-miRNA structures C Mattioli, G Pianigiani, F Pagani Nucleic acids research 41 (18), 8680-8691, 2013 | 26 | 2013 |
| Unusual splice site mutations disrupt FANCA exon 8 definition C Mattioli, G Pianigiani, D De Rocco, AMR Bianco, E Cappelli, A Savoia, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (7 …, 2014 | 18 | 2014 |
| Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML G Pianigiani, A Gagliardi, F Mezzasoma, F Rocchio, V Tini, B Bigerna, ... Blood Advances 6 (22), 5938-5949, 2022 | 13 | 2022 |
| Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice P Sportoletti, D Sorcini, AG Guzman, JM Reyes, A Stella, A Marra, ... Leukemia 35 (7), 1949-1963, 2021 | 13 | 2021 |
| Microprocessor-dependent processing of splice site overlapping microRNA exons does not result in changes in alternative splicing G Pianigiani, D Licastro, P Fortugno, D Castiglia, I Petrovic, F Pagani RNA 24 (9), 1158-1171, 2018 | 13 | 2018 |
| IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML VM Perriello, MC Rotiroti, I Pisani, S Galimberti, G Alberti, G Pianigiani, ... Blood Advances 7 (12), 2855-2871, 2023 | 11 | 2023 |
| Rescue of common exon‐skipping mutations in cystic fibrosis with modified U1 snRNAs S Donegà, ME Rogalska, G Pianigiani, S Igreja, MD Amaral, F Pagani Human Mutation 41 (12), 2143-2154, 2020 | 10 | 2020 |
| PU. 1 subcellular localization in acute myeloid leukaemia with mutated NPM1 G Pianigiani, C Betti, B Bigerna, R Rossi, L Brunetti British Journal of Haematology 188 (1), 184-187, 2020 | 9 | 2020 |
| Understanding the genetic complexity of puberty timing across the allele frequency spectrum KA Kentistou, LR Kaisinger, S Stankovic, M Vaudel, E Mendes de Oliveira, ... Nature Genetics, 1-15, 2024 | 5 | 2024 |
| CD123 and CD33 co-targeting by balanced signaling on CAR-CIK cells reduces potential off-target toxicity while preserving the anti-leukemic activity of acute myeloid leukemia VM Perriello, MC Rotiroti, I Pisani, G Alberti, G Pianigiani, R Rossi, ... Blood 138, 1699, 2021 | 5 | 2021 |
| A novel mutation in the vWFA2 domain of the COCH gene in an Italian DFNA9 family F Faletra, N Pirastu, E Athanasakis, A Somaschini, G Pianigiani, ... Audiological Medicine 9 (1), 4-7, 2011 | 4 | 2011 |
| The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein G Pianigiani, F Rocchio, S Peruzzi, V Andresen, B Bigerna, D Sorcini, ... Leukemia 36 (7), 1931-1934, 2022 | 2 | 2022 |
| Response to:“Cytoplasmic dislocation of NPM1 and PU. 1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” G Pianigiani, C Betti, L Brunetti British journal of haematology 189 (3), 577-578, 2020 | 2 | 2020 |
| Tuned IL3-Zetakine coupled to a CD33 costimulatory receptor as a dual CAR for safer and selective targeting of acute myeloid leukemia VM Perriello, MC Rotiroti, I Pisani, S Galimberti, G Alberti, G Pianigiani, ... Blood 140 (Supplement 1), 10237-10238, 2022 | 1 | 2022 |
| Challenging Occam’s Razor: Dual Molecular Diagnoses Explain Entangled Clinical Pictures B Spedicati, A Morgan, G Pianigiani, L Musante, E Rubinato, A Santin, ... Genes 13 (11), 2023, 2022 | 1 | 2022 |
